Heart supplements: Best supplements for the heart to avoid heart disease

SUPPLEMENTS could help lower the chance of having a heart attack or other related problem. For people who have a family history of cardiovascular disease or those who simply want the healthiest heart possible, which are four of the best supplements for a healthy heart?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

HEART ATTACK can strike suddenly and the consequences can be fatal. Lifestyle factors can raise the risk of developing heart disease and having a heart attack. Evidence suggests it could be linked to a common condition.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
AbstractCardiovascular disease (CVD) is emerging as a major threat to healthy aging among people with HIV (PHIV). PHIV face heightened risks for coronary heart disease (CHD)/myocardial infarction (MI) and heart failure (HF), fueled by systemic immune activation and by metabolic dysregulation. Women with HIV (WHIV) evidence unique patterns of vascular and myocardial pathology as compared to men with HIV (MHIV). These patterns include a predilection to microvascular dysfunction and type II MI, as well as a penchant for diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF). Investigations are underw...
Source: Current Treatment Options in Cardiovascular Medicine - Category: Cardiology Source Type: research
People who ate fried foods one to three times a week had a 7% higher risk of heart attack and stroke compared to those who ate fried foods less than once a week. For those who ate fried foods daily, the risk jumped to 14% higher.
Source: WebMD Health - Category: Consumer Health News Source Type: news
HEART attacks or coronary heart disease is a major cause of death both in the UK and worldwide. Spotting symptoms are crucial for protecting yourself from developing a heart attack. What are the two unusual signs that mean you might be at risk?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Coronary heart disease (CHD) is a major cause of death worldwide [1]. It is characterized by cholesterol-containing deposits in the major heart blood vessels, which results in angina, shortness of breath, fatigue and myocardial infarction [2]. The number of survivors is growing due to an aging population, and advancement in CHD treatment and management [3,4]. Most of the research on survivorship has focused on morbidity and mortality, however there is increasing awareness that quality of life (QoL) is also an important health indicator [5,6].
Source: Maturitas - Category: Primary Care Authors: Source Type: research
Conclusion: Reduced salt intake, omega-3 LC-PUFA use, and folate supplementation could reduce risk for some cardiovascular outcomes in adults. Combined calcium plus vitamin D might increase risk for stroke. Primary Funding Source: None. PMID: 31284304 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
Trimethylamine N-oxide (TMAO), a gut microbe-derived metabolite of dietary choline and other trimethylamine-containing nutrients, has been associated with poor prognosis in coronary heart disease. However, the role and underlying mechanisms of TMAO in the cardiac fibrosis after myocardial infarction (MI) remains unclear.
Source: Journal of Molecular and Cellular Cardiology - Category: Cytology Authors: Source Type: research
Researchers at the University of Bristol have developed a way to make stem cells move toward heart tissue when they are injected intravenously. The treatment could improve the efficacy of stem cell therapies for heart disease, which are currently ham...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiac Surgery Cardiology Genetics Rehab Source Type: blogs
Abstract Nintedanib is a tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis (IPF). We investigated the cardiovascular (CV) safety of nintedanib using pooled data from the TOMORROW and INPULSIS® trials.CV events were assessed post-hoc in patients with a history of atherosclerotic CV disease (CVD) and/or ≥1 CV risk factor at baseline ("higher CV risk") and patients with no history of atherosclerotic CVD and no CV risk factors at baseline ("lower CV risk").Incidence rates were calculated for 1231 patients (723 nintedanib, 508 placebo), of whom 89.9% had higher CV risk. In...
Source: Respiratory Care - Category: Respiratory Medicine Authors: Tags: Eur Respir J Source Type: research
Abstract Ischemic heart disease is the leading cause of death worldwide. Stem cell therapy to repair and regenerate the infarcted myocardium is a promising approach to address this unmet medical need. However, the poor survival of transplanted cells in the hostile ischemic myocardium has been a major hurdle in achieving an effective cell therapy against myocardial infarction. As such, novel strategies to promote the survival of transplanted cells are highly sought after. Mitochondria are intimately involved in cell survival and have been the main organelles being targeted for cytoprotection. Mitochondrial morpholo...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
More News: Cardiology | Cardiovascular | Health | Heart | Heart Attack | Heart Disease